Latest therapeutics News | Page 5

Micro/nano research makes big impact on life-changing technology
Telix reports its first quarter of $100 million in revenue
University spinout Complement Therapeutics secures €72 million to tackle diseases including leading cause of blindness
Slippery slope – basic research underfunded in Australia
Health Policy Symposium: What is future of medicine?
Cynata receives ethics approval for proposed aGvHD Phase 2 clinical trial
American Gastroenterological Association invests in unsedated transnasal endoscopy medical device company, EvoEndo®
Improving access to novel COVID-19 treatments
Member spotlight: Meet Dr Leanne Teoh
How Virtual Reality Can Help Relieve Chronic Pain
New strategy to prevent cardiovascular disease hidden in toxic waste product
Social solution – rare ovarian cancer insights
Chimeric Therapeutics reports ‘positive feedback’ on plan for CHM 2101
New funding will boost RNA research into vaccines and other healthcare treatments
New way to study molecular drivers of cancer
Antibody fragment-nanoparticle therapeutic eradicates cancer
New technology maps where and how cells read their genome
Clinical trial success for psoriasis drug
Right Cocktail of Gut Enzymes Can Stop C. diff in its Tracks
AstraZeneca launches call for entries to the 2023 global R&D Postdoctoral Challenge
ASIC continues its focus on improved material business risk disclosure in annual reports
FDA grants ‘orphan’ designation to PTX-100 for broader TCL indications
Chimeric Therapeutics advances manufacture of CHM 2101 viral vector
GreenLight Clinical and Cure Therapeutics look to future collaboration
Revolutionary new cholesterol drug to save lives
Human norovirus GII.4 exploits unexpected entry mechanism to cause gastroenteritis
New senior gender equity fellow
Two-pronged approach to target critical malaria protein
Crocodiles could save us from deadly infections
Supplies secured of latest Moderna COVID-19 vaccine as recommended by Halton Review
Early results of gene therapy trial for ‘childhood dementia’ show promise
Noxopharm to present Sofra study at international LUPUS 2023 conference
Genetic links between migraine and blood sugar levels confirmed
Global leader to operate $96 million RNA facility at Macquarie University
Two UQ CRC Projects receive funding support
WA launches inaugural Health and Medical Research Strategy
On-demand male contraceptive shows promise in preclinical study
Medication for potential treatment of anxiety disorders and postpartum depression to progress to next stage of clinical trials
AcuraBio partners with Cytiva to alleviate supply constraints for mRNA, cell and gene therapies
‘Magic’ solvent creates stronger thin films
Research Reveals Why Cancers Stop Responding to Kinase-Blocking Drugs and Come Back Stronger
Biotech partnership to develop new therapies
Less lung tissue removal needed for early stage cancer
Argenica Therapeutics releases preclinical study data on its ARG007
Long-distance treatment for brain disorders
Immutep reaches enrolment target for INSIGHT-003 trial in first line NSCLC
Long-standing mystery about mRNAs resolved
Antisense Therapeutics announces outcomes in DMD combination animal study